Evaluating Renal Transplant Status Using Viscoelastic Response (VisR) Ultrasound.
Evaluating Renal Transplant Status Using Viscoelastic Response (VisR) Ultrasound.
复制标题
DOI:
10.1016/j.ultrasmedbio.2018.03.016
复制
发表时间:
2018-08
影响因子:
2.9
通讯作者:
Gallippi CM
中科院分区:
文献类型:
--
作者:
Hossain MM;Selzo MR;Hinson RM;Baggesen LM;Detwiler RK;Chong WK;Burke LM;Caughey MC;Fisher MW;Whitehead SB;Gallippi CM
Chronic kidney disease is most desirably and cost-effectively treated by renal transplantation, but graft survival is a major challenge. While irreversible graft damage can be averted by timely treatment, intervention is delayed when early graft dysfunction goes undetected by standard clinical metrics. A more sensitive and specific parameter for delineating graft health could be the viscoelastic properties of the renal parenchyma, which are interrogated noninvasively by Viscoelastic Response (VisR) ultrasound - a new acoustic radiation force (ARF)-based imaging method. Assessing the performance of VisR imaging for delineating histologically confirmed renal transplant pathologies, in vivo, is the purpose of this study. VisR imaging was performed in patients with (n = 19) and without (n=25) clinical indication for renal allograft biopsy. The median values of VisR outcome metrics (τ, relative elasticity (RE), and relative viscosity (RV)) were calculated in five regions of interest (ROIs) that were manually delineated in the parenchyma (outer, center, and inner) and in the pelvis (outer and inner). The ratios of a given VisR metric for all possible ROI combinations were calculated and the corresponding ratios were statistically compared between biopsied patients subdivided by diagnostic categories versus non-biopsied, control allografts using the two-sample Wilcoxon test (p < 0.05). While τ ratios nonspecifically differentiated allografts with vascular disease, tubular/interstitial scarring, chronic allograft nephropathy, and glomerulonephritis from non-biopsied control allografts, RE only distinguished allografts with vascular disease and tubular/interstitial scarring, and RV distinguished only vascular disease. These results suggest that allografts with scarring and vascular disease can be identified using noninvasive VisR RE and RV metrics.
登录
查看更多内容
影响因子:
2.9
作者:
Gao, Jing;Weitzel, William;Min, Robert
通讯作者:
Min, Robert
影响因子:
8.8
作者:
Cosio, FG;Grande, JP;Stegall, MD
通讯作者:
Stegall, MD
影响因子:
3.1
作者:
Lagarias, JC;Reeds, JA;Wright, PE
通讯作者:
Wright, PE
影响因子:
3.7
作者:
Guo LH;Xu HX;Fu HJ;Peng A;Zhang YF;Liu LN
通讯作者:
Liu LN
影响因子:
3.1
作者:
Arndt, Robert;Schmidt, Sven;Westhoff, Timm H.
通讯作者:
Westhoff, Timm H.